Low dose versus high dose imatinib for gastrointestinal stromal tumors

J. Verweij, C. Blanke

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)76-77
Number of pages2
JournalNature Clinical Practice Gastroenterology and Hepatology
Volume2
Issue number2
DOIs
StatePublished - Feb 1 2005

Keywords

  • Gastrointestinal stromal tumors
  • Imatinib
  • Progression-free survival

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this